Our dedication to safe, effective weight loss and individualized care forms the bedrock of our approach
As new evidence emerges, strategies to prevent sarcopenia during GLP-1 therapy are becoming essential components of care for older adults
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet 398(10317):21602172
The results of two drug trials were presented at the American Diabetes Associations annual meeting
Its not dramatic, but its directional
During rapid weight loss, your body breaks down both fat and muscle tissue for energy